Mazdutide

Mazdutide is China’s first approved dual GLP-1/glucagon receptor agonist for obesity, delivering 14.8% weight loss at 6mg weekly (48 weeks) via appetite reduction plus increased energy expenditure targeting liver, brain, and adipose remodeling—83% of patients achieve ≥5% loss versus 11.5% placebo, with 50.6% reaching ≥15%. Lilly/Innovent collaboration yields first-in-class GCG/GLP-1 synergy, enhancing fat oxidation beyond GLP-1 alone.

Route

Subcutaneous injection

Dose range

2.5 mg – 5 mg

Frequency

Once per week (subcutaneous injection)

Cycle length

8–12 weeks

Not currently stocked by N1 Aminos. Browse what is in stock →

Overview

Mazdutide is China’s first approved dual GLP-1/glucagon receptor agonist for obesity, delivering 14.8% weight loss at 6mg weekly (48 weeks) via appetite reduction plus increased energy expenditure targeting liver, brain, and adipose remodeling—83% of patients achieve ≥5% loss versus 11.5% placebo, with 50.6% reaching ≥15%. Lilly/Innovent collaboration yields first-in-class GCG/GLP-1 synergy, enhancing fat oxidation beyond GLP-1 alone.

Phase 3 GLORY-1 data confirm robust efficacy in overweight/obese Chinese adults, positioning mazdutide as regional GLP-1 market disruptor. For BMI ≥27kg/m² populations, it offers weekly injectable metabolic transformation with hepatic benefits.

Studied benefits

  • A once-weekly dual agonist that produces significant weight loss (up to 14%) and meaningful improvements in HbA1c and lipid profiles
  • It offers a convenient dosing schedule for managing obesity and type 2 diabetes

Reported side effects

  • Most common are gastrointestinal (nausea, vomiting, diarrhea), which typically diminish over time
  • Gradual dose titration is recommended to minimize these effects

Protocol

Dosing Schedule (Subcutaneous)

Educational reference only. Not medical advice. Research compounds are not approved for human use. Full disclaimer.

Mazdutide (5mg)

Reconstitute with 3.0 mL bacteriostatic water (Final concentration: ~1.67 mg/mL).

Support chronic weight management and metabolic improvement through dual GLP-1/glucagon receptor activation.

Mazdutide (10mg)

Reconstitute with 3.0 mL bacteriostatic water (Final concentration: ~3.33 mg/mL).

Support chronic weight management and metabolic improvement through dual GLP-1/glucagon receptor activation.

WeekWeekly DoseDraw at 1.67 mg/mLLog
Weeks 1–42.5 mg (2,500 mcg)150 units (1.5 mL)+ Log
Weeks 5–8+5 mg (5,000 mcg)300 units (3 mL)+ Log

Frequency

Once per week (subcutaneous injection).

Timing

Administer on the same day each week; rotate injection sites to avoid irritation.

Cycle length

8–12 weeks.

Unit calculator

Set your vial and water; the table above updates.

Open the full calculator →
Concentration

1.67 mg/mL

2 doses of 2.5 mg per vial

At the starting dose (2.5 mg × 1/week for a 8-week cycle) you would use about 20 mg, i.e. 4 × 5 mg vials. Higher phases use proportionally more.

Assumes a U-100 insulin syringe (100 units = 1 mL). Educational math only; verify every calculation yourself.

Context

Lifestyle considerations

Follow a high-protein, nutrient-dense diet to support healthy body composition while this dual GLP-1/Glucagon receptor agonist targets weight loss and improved lipid metabolism. Incorporate both resistance and aerobic exercise to utilize the increased fatty acid oxidation and metabolic rate triggered by the glucagon component. Ensure 7–9 hours of quality sleep to support hormonal balance and prevent cortisol-driven hunger cues. Maintain optimal hydration and monitor for gastrointestinal adjustments, using small, frequent meals to manage the peptide's satiety-promoting effects without causing discomfort.

Evidence

Research summaries

Mazdutide reduces body weight in adults with overweight or obesity: A high-dose Phase 1 trial

Findings: Big weight loss (up to more than what other doses did before), better control of blood sugar and fats in the body, less hunger.

In this test with adults who were overweight or obese, they gave mazdutide in shots up to 16 mg once a week for a few months. People lost a lot more weight with higher doses—like way more than lower ones tried before. For example, the highest dose led to strong weight drop while also fixing things like blood sugar levels after not eating and making people feel less hungry. It helped their body's fuels (like fats and sugars) stay balanced better. Side stuff was mostly tummy troubles that were mild, like upset stomach, but nothing super serious happened. This shows mazdutide could be a good pick for folks needing to shed pounds without big risks. The study was safe and proved higher amounts work even better for weight control and health tweaks.

Read the study ↗

Efficacy and safety of Mazdutide on weight loss among diabetic and non-diabetic patients: a systematic review and meta-analysis of randomized controlled trials

Findings: Cuts body weight by about 6%, lowers blood pressure, drops bad cholesterols and fats, helps blood sugar in diabetes folks.

Scientists looked at 7 different tests (called RCTs, which are super fair comparisons with fake pills) with 680 people, some with diabetes, some without. Mazdutide beat the fake pill big time: people lost around 6% of their weight on average. It also dropped top blood pressure by 7-8 points, bottom by 3, total cholesterol by 17%, bad fats (triglycerides) by 43%, and bad LDL cholesterol by 17%. For diabetes people, it lowered their long-term sugar mark (HbA1c) and morning sugar. Non-diabetics lost even more weight, and longer use (24 weeks) worked best. Tummy side effects like nausea happened more but were mild and went away fast. This big review proves mazdutide fights weight and heart risks safely for many people, like lowering chances of heart trouble or diabetes woes.

Read the study ↗

A phase 2 randomised controlled trial of mazdutide in Chinese overweight adults or adults with obesity

Findings: Weight down 7-12% (like 6-10 kg), slimmer waist, better blood pressure, fats, liver health, less inflammation.

This was a strong test with 248 Chinese adults who were overweight or obese (no diabetes). They got mazdutide shots (3, 4.5, or 6 mg weekly) or fake for 24 weeks. Weight fell hugely: 7% with low dose, 10% medium, 11% high—vs gaining 1% on fake. That's 6-10 kg gone! Waist got smaller by 6-9 cm, blood pressure dropped (especially high dose), bad cholesterols and fats improved, liver enzyme (ALT) down 20-30%, uric acid (tied to gout) way down, even swelling marker dropped. More than 80% hit 5% loss goal on higher doses, half hit 10%. Tummy issues like diarrhea/nausea were common but mild, went away, few quit. Body scans showed mostly fat loss, not muscle. Life quality got a bit better too. After stopping, some weight came back but still better than fake. Great for Asians with belly fat risks.

Read the study ↗

Efficacy and safety of Mazdutide on weight loss among diabetic and non-diabetic patients (PubMed abstract)

Findings: Stronger weight loss without diabetes, fixes sugar/blood pressure/cholesterol over placebo.

Same big review as above but from PubMed view—combines tests showing mazdutide shrinks weight more in non-diabetics, over longer time. Lowers HbA1c/fasting sugar for diabetics, all get blood pressure/cholesterol wins. Mild gut sides only. Confirms real-world help for obesity fights. These studies show mazdutide shines for weight drop and health boosts like heart-friendly changes. It's promising but needs more long tests. (Total chars: ~2850)

Read the study ↗
More references (4)

Identification

Chemistry

cas
2259884-03-0
formula
C₂₀₇H₃₁₇N₄₅O₆₅
molecular weight
Approximately 4,476 Da (or 4.48 kDa)
sequence
-
source
Synthetic; recombinant DNA-derived; engineered oxyntomodulin analog
biosynthesis
Recombinant protein production (bacterial expression systems); post-synthetic chemical modifications
type
Linear 31-amino acid peptide with post-translational modifications

Keep exploring

Related peptides

Educational use only. The protocols shown summarise published research and community practice for informational purposes. They are not medical advice, not a prescription, and not a recommendation to use any compound. Research peptides are generally not approved for human use. Consult a licensed clinician. Full disclaimer.
Ask the advisor